National Mental Health Non-Profit, One Mind, Awards $600000 in Grants to Two "Rising Stars" in Neuroscience and Psychiatry, Greg Fonzo, UT…

RUTHERFORD, Calif., Sept. 1, 2020 /PRNewswire/ -- National mental health and brain research non-profit, One Mind announced the award of a combined total of $600,000 to the two winners of its 2020 One Mind Rising Star Awards, Gregory A. Fonzo, Ph.D., Assistant Professor, Department of Psychiatry and Behavioral Sciences, University of Texas at Austin Dell Medical School, and Kevin T. Beier, Ph.D., Assistant Professor, Department of Physiology and Biophysics, University of California, Irvine.

Now in its 16th year, the Rising Star Awards support early career researchers in their investigation into neuropsychiatric disorders. Drs. Fonzo and Beier will each receive $300,000 in research support and will present their projects at the 26th Annual One Mind Music (virtual) Festival for Brain Health and Scientific Symposium, Saturday, September 12, 2020.

"One Mind is delighted to recognize and help fast-track the promising research and innovative methods that Dr. Beier and Dr. Fonzo bring to the investigation of the neurological basis of major psychiatric illnesses," said Brandon Staglin, president of One Mind. "At a moment when mental health issues loom large for so many impacted by the Covid-19 pandemic, research that will produce effective treatments is more critical than ever, and we're proud to support."

Dr. Fonzo is the recipient of the inaugural One Mind Baszucki Brain Research Fund Rising Star Award, which aims to grow the field of bipolar disorder research. Dr. Fonzo's research will investigate the potential for focused ultrasound to influence the circuitry of the brain and develop treatment tools for bipolar and other mood disorders. With the award, he will continue to investigate predictors of first-line psychiatric treatment response.

Dr. Beier is the recipient of the 2020 One Mind Janssen Rising Star Award in Memory of Jeffrey S. Nye, a Johnson & Johnson neuroscience researcher who passed away in 2017. Dr. Beier's research maps neural circuitry associated with depression vulnerability. The extension of this work will be to develop focused therapeutic strategies to treat depression, as well as to help identify those at risk for developing this disorder. To support his research, Beier will also receive a One Mind/Inscopix Technology Grant, which includes a state-of-the-art nVoke miniature microscope system, along with training and support for using the system.

This year's Rising Star Awards are sponsored by Janssen Research & Development LLC, and the Baszucki Brain Research Fund; since 2005, the One Mind Rising Star Awards have conferred a total of $9 million in research grants to 36 early-career neurology and psychiatry researchers. The awards are designed to catalyze innovation in the field by awarding novel approaches along with fostering greater collaboration among research teams.

In addition, One Mind announced the five winners of its inaugural One Mind Bipolar Research Awards for advancement in the understanding and treatment of bipolar disorder. Each of the five recipients will receive $20,000, thanks to additional financial support from the Baszucki Brain Research Fund.

Awardees include: Hirofumi Morishita, Ph.D., associate professor of psychiatry, Icahn School of Medicine at Mount Sinai, New York City; Paulo Lizano, Ph.D., M.D., instructor, Department of Psychiatry at Harvard Medical School; Ivy F. Tso, Ph.D., assistant professor of psychiatry, University of Michigan Medical School; Nolan Williams, M.D., assistant professor, Department of Psychiatry and Behavioral Sciences and director, Stanford Brain Stimulation Lab; and Alexander Urban, Ph.D., assistant professor, Department of Psychiatry and Genetics, Stanford University School of Medicine.

The recipients of the 2020 One Mind Rising Star Awards and the One Mind Bipolar Research Awards were selected with the assistance and recommendations of the ten-member One Mind Scientific Advisory Board, which includes leading brain scientists, noted for their pioneering research in their respective fields.

For more information about One Mind's Rising Star Awards, or to learn about the organization's many initiatives, visit http://www.OneMind.org.

About One Mind

Launched in 1995 by Shari and Garen Staglin as their means to "run toward the problem" of their son's schizophrenia diagnosis, One Mind is today a leading mental health non-profit that heals lives by direct support for neuropsychiatric brain research. By convening the brightest minds in brain science and advocacy around a collective vision of "Accelerating Brain Health for All," One Mind is advancing a three-pronged program strategy: accelerating discoveries, improving services and transforming culture. Through such achievements as enrolling over 10,000 patients in innovative clinical studies and the One Mind at Work initiative that has brought supportive workplace mental health practices to over 6 million employees, One Mind is creating a world where all facing brain health challenges can build healthy, productive lives. Brandon Staglin, whose own experiences triggered the creation of the non-profit, now serves as its President, exemplifying the change One Mind seeks in its disruptive research and workplace initiatives.

onemind.org| facebook.com/OneMindOrg | Instagram.com/OneMindOrg |twitter.com/OneMindOrg

Janssen Research & Development, a longtime One Mind research partner,is part of Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Baszucki Brain Research Fund is supported by San Mateo philanthropists David Baszucki and Jan Ellison Baszucki.

Inscopixhas developed technology that is empowering breakthroughs in neuroscience, with the vision to drive new treatments to dramatically improve the health and well-being of people suffering from debilitating brain and nervous system disorders. The Inscopix platform and data will enable advances in conditions including Alzheimer's, Parkinson's, psychiatric disorders, chronic pain, and addiction.

SOURCE One Mind

Read the original here:
National Mental Health Non-Profit, One Mind, Awards $600000 in Grants to Two "Rising Stars" in Neuroscience and Psychiatry, Greg Fonzo, UT...

West Virginia University Uses Tech to Track and Predict Coronavirus Outbreaks – Cheddar

West Virginia University hopes students are returning to campus with added peace of mind thanks to the school's coronavirus research. WVU's Rockefeller Neuroscience Institute says it can now predict COVID-19 symptoms up to three days in advance with 90 percent accuracy.

"We're deploying a new technology that uses a wearable ring and an app that you put on your phone that allows us to predict the onset of viral symptoms," Dr. Ali Rezai, executive chair of WVU's Rockefeller Neuroscience Institute told Cheddar. The ring is able to track multiple bodily functions like heart rate, temperature, and respiratory rates.

The accessory is used in conjunction with an app called NOVID, the first anonymous contact tracing app in the U.S. It uses ultrasonic technology to track how close users are to other people and can alert them when they've been in contact with someone who tested positive for the virus. NOVID's creators say the ultrasonic technology is more accurate than Bluetooth or GPS technology when it comes to contact tracing.

WVU is only able to predict these outbreaks thanks to a recent study that focuses on the days before a person shows symptoms, but is already infected and spreading the virus. WVU has been studying what happens inside the human body during this asymptotic phase for the past five months. The research involved more than 1,000 individuals, including healthcare professionals and people on the front lines of the pandemic.

"The key is this asymptomatic phase where you feel fine, yet you are spreading the virus," Dr. Rezai said.

By giving students and faculty the feedback that they may be infected, the school is hoping it can prevent outbreaks before they happen. "This allows individuals to get feedback from the machine learning technology that allows them to be in-the-know and be smarter about the fact that they're going to have, three days from now, symptoms of COVID-related illnesses," said Dr. Rezai.

The study is now happening on campus, involving the adults that are most susceptible to the virus. "We're using this for faculty, teachers, maintenance workers, cafeteria workers, athletic personnel, and all the individuals that are interacting with the students in a study of 300 individuals," he said.

Right now WVU is enacting a phased reopening of campus, with just freshmen and other students whose classes require in-person training like labs.

"Everybody has been undergoing training and awareness campaigns from the time before you start, to ongoing additional emails and texts," Dr. Rezai told Cheddar.

Read the original post:
West Virginia University Uses Tech to Track and Predict Coronavirus Outbreaks - Cheddar

Neurology care during the COVID-19 pandemic, an interventional neurologist’s perspective – Boca Newspaper

By: David DiPinoContributing Writer

Nils Mueller-Kronast, MD, an interventional neurologist with Palm Beach Neuroscience Institute (PBNI) continues to provide care during the COVID-19 Pandemic for a wide variety of neurological ailments and neurovascular diseases including stroke and brain aneurysm treatment.

At Dr. Nils Mueller-Kronasts PBNI office, safety protocols and guidelines continue to be in place and telehealth appointments are available. Those safety procedures include patient screening for fever and cough, following the Centers for Disease Control and Preventions (CDC) guidelines for social distancing by maintaining six-feet of distance between individuals in the waiting area and exam room and continuous wearing of masks by staff. In addition, Dr. Mueller-Kronast and his care staff wear gloves and masks during patient consultations, and the offices and waiting areas are routinely sanitized.

Healthcare providers take great efforts to ensure patient and staff safety during an office consultation by limiting the physical exam when appropriate, maintaining social distance during the consultation while wearing personal protective equipment (PPE) throughout the encounter. We also provide telehealth for new patients and follow-up appointments for added convenience and patient safety, said Dr. Mueller-Kronast.

Telehealth appointments may be appropriate when the neurological disease does not require a physical exam.

Bi-directional video and audio conferences provide an excellent patient experience without the inconvenience and perceived uncertainty of an in-person visit. If chosen for the correct patient and condition, there does not have to be a negative impact to not being in-person with the patient during the interaction and telehealth can allow us to determine the correct diagnosis and treatment, said Dr. Mueller-Kronast.

Additionally, Dr. Mueller-Kronast encourages going to the hospital for serious ailments and elective procedures.

In the hospital patients who are suspected of COVID-19, or are COVID-19 positive, are managed by separate staff in separate areas of the hospital. We also use telehealth to minimize staff exposure when feasible. All elective surgery patients are COVID-19 tested, said Dr. Mueller-Kronast.

As for the link between COVID-19 and stroke, Dr. Mueller-Kronast has seen rare occurrences.

Early during the first months of the epidemic, in certain hot spots, some hospitals reported a spike in embolic large vessel occlusion in COVID-19 positive patients. We have seen a few COVID-19 positive stroke patients with typically more severe disease but, as in many parts of the country, there appeared to be a hesitancy of patients to present to the emergency room, said Dr.Mueller-Kronast.

Lastly, Dr. Mueller-Kronast encourages our communities to continue making efforts in preventing the spread of the COVID-19 virus.

These are difficult times, and we have to take this disease seriously. Everyones efforts are required to minimize the risk of exposure for our most vulnerable members of society. I feel that wearing a mask to protect someone else from a potentially deadly disease is a small burden which I will happily shoulder, said Dr. Mueller-Kronast.

Dr. Nils Mueller-Kronast is an interventional neurologist with the Palm Beach Neuroscience Institute and is on-staff at Delray Medical Center in Delray Beach, St. Marys Medical Center in West Palm Beach and Florida Medical Center, a campus of North Shore located in Fort Lauderdale. In addition, Dr. Mueller-Kronast is the Regional Medical Director of Neurosciences for Tenet Healthcares Florida Region.

Dr. Mueller-Kronast specializes in stroke, vascular neurology office consultations, endovascular management of elective and ruptured aneurysm, endovascular management of vascular malformations (dural AV fistulas, arteriovenous malformations), intra-arterial stroke treatment, carotid, intracranial and other cerebrovascular stents. His Palm Beach Neuroscience Institutes offices are located in Boynton Beach, West Palm Beach and Sunrise, FL. Dr. Mueller-Kronasts Boynton Beach office is located at: 8756 Boynton Beach Blvd., Suite 2500, Boynton Beach, FL 33472. For more information visit: http://www.PBNI.com or call 561-499-7551.

Visit link:
Neurology care during the COVID-19 pandemic, an interventional neurologist's perspective - Boca Newspaper

Studies by AHN Neurologists Improve Understanding of Stroke Therapy Risks in Patients with Chronic Health Conditions – Vascular Disease Management

Pittsburgh, Pa (Sept. 2, 2020) Intravenous thrombolysis may put stroke patients with chronic kidney disease (CKD) at a higher risk for intracranial bleeding and mortality, according to a recent study published in the journal Neurology by researchers at the Allegheny Health Network (AHN) Neuroscience Institute. The study, Intravenous thrombolysis in patients with chronic kidney disease: A systematic review and meta-analysis, surveyed various studies published across different countries and assessed the association of CKD among more than 60,000 acute ischemic stroke patients undergoing IV thrombolytic therapy.

According to the CDC, stroke kills about 140,000 Americans each year, accounting for approximately one out of every 20 deaths. Nearly 90 percent of strokes are classified as acute ischemic strokes which take place when a blood clot or narrowed artery obstructs blood flow to the brain. Within minutes, the lack of oxygenated blood to the brain can cause a severe, permanent neurological injury, and even death.

Patients who suffer an acute ischemic stroke and arrive early to the hospital are often administered IV thrombolysis to dissolve dangerous clots in blood vessels, improve blood flow, and prevent damage to tissues and organs, said Konark Malhotra, MD, vascular neurologist at Allegheny General Hospital (AGH) and the AHN Neuroscience Institute, and principal investigator of the study. We wanted to better understand how this course of treatment with IV thrombolytic therapy may impact an already vulnerable population with a specific chronic condition like chronic kidney disease.

In the systematic review, Dr. Malhotra and his colleagues evaluated outcomes with special attention being paid to intracranial bleeding, three-month mortality and functional independence rates with regard to a patients mobility and ability to maintain high levels of self-sufficiency.

Across 20 independent studies that were analyzed, a significant correlation was determined to exist between CKD and worsened clinical outcomes most notably, a higher risk of intracranial bleeding and mortality.

The primary causation of worsened outcomes presents an opportunity for further research. A likely contributing factor is the high rate of comorbidities seen in the study population; for example, hypertension and diabetes are the leading causes of chronic kidney disorder, said Ashis Tayal, MD, neurologist and director of the AGH Stroke Center.

In addition to Dr. Malhotra and Dr. Tayal, other neurologists who contributed to the study include Aristeidis H. Katsanos, Nitin Goyal, Henrik Gensicke, Panayiotis D. Mitsias, Gian Marco De Marchis, Eivind Berge, Anne W. Alexandrov, Andrei V. Alexandrov and Georgios Tsivgoulis.

In anotherstudypublished earlier this year in the AHA Journal ofHypertension, Dr. Malhotras team provided additional insight on how clinical outcomes of acute ischemic stroke patients who undergo stroke thrombectomy procedures are impacted by elevated blood pressure levels.

Dr. Malhotra performed a systematic review and pooled results from 25 published studies involving 6,500 patients who underwent acute stroke thrombectomy. This study analyzed the association of blood pressure systolic and diastolic before, during or after acute stroke thrombectomy with various clinical outcomes. The authors found that higher blood pressure levels negatively affect stroke related outcomes such as intracranial bleeding, death and functional independence in daily living.

Studies such as those led by Dr. Malhotra and his team are essential to improving our understanding of chronic disease management and developing better therapeutic strategies that can make a life-changing difference for stroke patients, continued Dr. Tayal.

AHN was recently recognized by the American Stroke Association for its excellence in stroke care. In August, the Network announced six Network hospitals earned Gold Plus Elite and Silver Plus designations for its adherence to guideline-directed therapies and protocols which in turn improves patient outcomes and decreases stroke recurrence rates.

For more information on the AHN Neuroscience Institute, visit ahn.org.

See the original post here:
Studies by AHN Neurologists Improve Understanding of Stroke Therapy Risks in Patients with Chronic Health Conditions - Vascular Disease Management

What’s the Physiological Relevance? A Profile of Oded Rechavi – Technology Networks

As a Professor in Molecular Biology at Tel Aviv University in Israel, it would be easy to assume that Oded Rechavi's career in science was written in his biology his entire family are scientists or clinicians. His father, Gidi Rechavi, a well-regarded professor of hematology, won the Israel Prize 2020 in the field of medicine. But this was not the case.Growing up, Rechavi always thought of his father as a medical doctor rather than a scientist. As such, research was not a regular topic at the dinner table in his household: "We didn't really talk about experiments, research or journals, so I didn't know that research existed as a profession." As he puts it, he was raised in an environment to produce scientists, but it affected him indirectly: "I couldn't control it."

Rechavi's first love was art and he speaks of it with fervour. After completing military service mandatory for Israeli citizens he traveled to Paris, immersing himself in the Parisian culture and exploring the local art galleries for six months. Upon returning to Israel, he was prompted by family members to consider studying at university.

During an undergraduate project, Rechavi found himself in the lab of the highly-regarded biochemist Prof. Yoel Kloog, where he also became acquainted with Dr Barak Rotblat. Rotblat says that, despite being at an early stage in his career, Rechavi was ambitious and did not shy away from proposing research ideas to the team: "I remember one of the first meetings Oded and I had with Yoel. Oded had an idea that the protein we were studying (RAS) can move from one cell to the other, and to use the interaction between immune cells and their targets as a system to test this idea. Yoel and I looked at each other and laughed because we were thinking that RAS might travel between cells, but we did not know how to test this!". Rechavi says that Kloog, who sadly passed away last year, was his role model a true friend that treated him like he was his son.

Rechavi had been in love with New York City (NYC) since he was a teenager, and the idea of living there had been a longstanding dream: "I used to go to NYC with my family fantasizing about jogging in Central Park and going to Knicks games." He chose to do his postdoc in NYC because, as the song goes, "if you make it there, you'll make it anywhere". Rechavi and his wife, who is a designer, loved their time in the city that never sleeps: "Its a tough city to work in, but its worth it. The atmosphere, and the scientific scene, are incomparable.

When the opportunity arose for Rechavi to start his own laboratory at Tel Aviv University in 2012, he decided to paint outside of the lines. He wanted to create something unique and "radical" quite literally his lab is headlined as "the laboratory for radical science".

Bruce Springsteen's lyrics from Dancing in the Dark: "You can't start a fire without a spark" are displayed on the research section of the lab's website. Fire in your belly a true craving for discovery are the prerequisites for thriving here it seems.

Acquired traits are not coded in your DNA (as most inherited traits are) they are developed during your lifetime. Theoretically speaking, we should not be able to inherit acquired traits. Say you burnt your arm on the hob and it caused a scar to form on your skin. Your offspring would not be born sporting the same scar. That's because the scar has caused a change in the somatic cells, and only germline cells are able to transmit DNA to future generations. This is the Second Law of Biology.

Rechavi's interest lies not with DNA but with its cousin small RNA. Small RNAs are non-coding RNA molecules that regulate gene activity via an array of different mechanisms in both the nucleus and the cytoplasm in response to changes in environmental stimuli.1 The transgenerational epigenetic inheritance theory posits that the methods by which genes are turned "on" or turned "off" in this manner could perhaps be passed on to the next generation.

It's a phenomenon that is inexplicably tricky to study in humans, but a number of interesting occurrences throughout history have given weight to the idea. L.H Lumey's Dutch Hunger Winter Families Study found that descendants of the Dutch population that survived the famine of 19441945 had higher levels of low-density lipoprotein cholesterol, higher rates of obesity, schizophrenia and diabetes in adult life.2 The famine had ended long before their time, but did the descendants still carry the scars in their biological makeup?

Rechavi's research on transgenerational inheritance focuses on the Caenorhabditis elegans (C. elegans) worm model, which he finds "irresistible", and is suitable for such experiments because of its short lifetime and the large number of genetically identical offspring each mother produces. Over the last decade, his laboratory has demonstrated that a number of different events, experienced by a C. elegans worm, can impact the physiology of their offspring.

Through a series of genetic experiments, the scientists discovered that inducing expression of the Flock House virus in C. elegans results in the production of small-interfering RNA molecules that essentially silence the viral genome. These molecules are extragenetic, and yet they are transmitted to the next generation of the worm, providing "vaccination" against the virus in the offspring.3 When starved, a number of small RNAs are induced in C. elegans that regulate genes implicated in nutrition, and these small RNAs are also expressed in the progeny for at least three generations.4 These studies are the first direct evidence that an acquired trait can indeed be inherited.

Video credit: TEDx talks.

"There's a feedback mechanism that shuts down the inheritance after three to five generations. This feedback mechanism is small RNA-based, but there are genes that modulate the inheritance of these small RNAs that function as a timer. We named them MOTEK genes, which stands for modified transgenerational epigenetic kinetics, and means sweetheart in Hebrew that was a sort of a joke that only Hebrew speakers would understand," Rechavi explains. In mutant worms where these genes are engineered to be defective, the transgenerational responses last for different periods of time, with some being present for hundreds of generations.

He likens the third and final rule to the "hot hand" phenomenon. If you want to assess whether an inheritance response will continue or stop at the individual level, you look at the history of the lineage. Lineages in which responses have been silenced for multiple generations are more likely to continue the silencing, whereas shorter lineages are more likely to stop the response."

Caption: Dr Leah Houri-Zeevi, the paper's first author, creatively describes the key study findings in a Twitter thread.

He had been researching the remnants of the Dead Sea Scrolls, 25,000 fragments of parchment that were discovered mainly in caves around the archaeological site Qumran in the Judean Desert, trying to piece them together. Among the scrolls are the oldest copies of biblical texts which shed light on the history of Judaism and Christianity, containing collections of hymns, prayers and the earliest version of the Ten Commandments. Unfortunately, their historical significance was not a factor of consideration for the worms that made a meal from the scrolls, creating holes in the parchment, part of what makes their reconstruction a phenomenal challenge.

On the bus journey, Rechavi and Mizrahi pondered on how they could join forces and use modern biological techniques to piece the fragments together. The parchments are written on animal skin, and so they hypothesized that, should they be able to extract the ancient animals' DNA, they could apply next-generation sequencing methods to deduce which fragment came from which animal, creating a "genotype" fingerprint, and in turn, piece together the ancient puzzle.

And so, by complete chance, a project that would unite ancient history and modern biology was born. It would take a total of seven years to reach publication, and as Rechavi explains, required a lot of energy: "We needed funding and to convince the authorities that this experiment would be possible without causing damage to the scrolls. It took more than two years to convince them and to conduct calibration studies amongst other experiments to demonstrate that it was possible to extract DNA from very small amounts of the scrolls."

Another string of accidents led to several collaborators joining the team, including Prof. Mattias Jakobsson of Uppsala University, an expert on ancient DNA analysis, who Rechavi happened to be introduced to whilst giving a talk in Uppsala University. "It was like in the film Ocean's Eleven, we collected people that could contribute their own strengths which is really a beautiful thing," Rechavi says.

The team generated over 2.6 billion sequencing reads, and in doing so, learnt a lot about the scrolls and their history. The genetic evidence allowed the researchers to distinguish between fragments that originated from different animals of the same species. If the fragments belonged to the same scroll, the likelihood is that they were from two different sheets. Furthermore, two of the fragments found were genetically different from all the other samples, indicating that they are unrelated to the scrolls.

Rechavi explains that, for him, the major highlight of this work was proving their hypothesis was true: "You can extract enough authentic DNA from pieces that are over 2000 years old and use it to learn about the relationships of the different fragments. Aside from the fact that it's cool, it shows how interdisciplinary science can have real value."

This was just the beginning of Rechavi's exploration into ancient history. The team sampled only a selection of the 25,000 fragments, so there is still a lot of work left to be done. In the short period of time since the paper was published, he has been contacted by a variety of researchers that are keen to collaborate on future studies to further unearth the secrets of the Dead Sea Scrolls, and learn more about the extracted ancient animal DNA. "I could never write a grant eight years ago explaining what we are going to do. This project is a living thing sometimes you just can't plan," says Rechavi.

In 2014, Nature conducted a survey of over 3,500 researchers across 95 different countries to enquire about their social media use. Twitter was used regularly by 13% of the survey respondents, with over half of those individuals stating that they utilized it to follow conversations relating to research. Fast forward six years online communities such as Academic Chatter and Open Academics are thriving, connecting scientific researchers from across the globe.

Rechavi also believes Twitter presents a solution to a prominent issue in the scientific community cliques. "When you go to scientific meetings and you don't know anyone, you just meet with the same people that have been attending for years. I think that the new connections people form on Twitter are really breaking down hierarchies and allowing science to be free and more enjoyable," he says.

It was this love of new connections and forming friendships that led to Rechavi adding conference producer to his resume, after he organized "The Woodstock of Biology" event earlier this year.

"On a Friday night, I posted a tweet saying that I would be happy to organize a conference for the people that I like on Twitter. I thought it would be nice to know these people in person, and I have a lot of friends on Twitter that I have never met.

When he awoke the next morning, Rechavi was greeted with hundreds of positive responses and decided that he would pursue organizing the conference. The Woodstock of Biology was born, and it was to be "different" from a traditional scientific meeting, he says, "I wanted no hierarchy, I wanted no selection everyone who wanted to present and signed up on time was allowed to. You were also only allowed to present unpublished work, which is very unusual."

Talks were restricted to 10-minute slots, and rather than having a strict agenda, each presenter had to choose a "walk up" song that would be selected at random and, when played, would signal to the scientist that it was their turn to present. "We wanted to surprise them and keep the speakers on their toes, so that they wouldn't disappear or go drink coffee," Rechavi says.

He adds, "It was like a big party. I enjoyed it tremendously, and I think others did too." If Twitter testimonies are anything to go by, The Woodstock of Biology conference was very well received.

Deep emotion is apparent in his voice when he discusses one attendee's story who is kept anonymous for the purpose of this article. "He spoke of how he was sick of some aspects in science, of the usual hustle, trying to get funded, being forced to publish and stay focused. He had lost interest and wanted to quit or make a change. Whilst on stage he said that the conference had saved him. He now saw the light, and it gave him the energy and motivation to continue in science. It was an unbelievable moment."

The COVID-19 global pandemic has not impeded Rechavi's plans to run a second The Woodstock of Biology conference sometime in the future, when it is safe to do so. If anything, the apparent success of online conferences during this time adds further credence to his philosophy that there are other perhaps better ways of sharing and interacting with research than tradition tells us.

Oded Rechavi was speaking to Molly Campbell, Science Writer for Technology Networks.*Correct as of September 3 2020.

References:

1. Stuwe E, Tth KF, Aravin AA. Small but sturdy: small RNAs in cellular memory and epigenetics.Genes Dev. 2014;28(5):423-431. doi:10.1101/gad.236414.113

2. Lumey L, Stein AD, Kahn HS, et al. Cohort Profile: The Dutch Hunger Winter Families Study. International Journal of Epidemiology. 2007;36(6):1196-1204. doi:10.1093/ije/dym126

3. Rechavi O, Minevich G, Hobert O. Transgenerational Inheritance of an Acquired Small RNA-Based Antiviral Response in C.elegans. Cell. 2011;147(6):1248-1256. doi:10.1016/j.cell.2011.10.042.

4. Rechavi O, Houri-Zeevi L, Anava S, et al. Starvation-Induced Transgenerational Inheritance of Small RNAs in C.elegans. Cell. 2014;158(2):277-287. doi:10.1016/j.cell.2014.06.020.

5. Anava S, Neuhof M, Gingold H, et al. Illuminating Genetic Mysteries of the Dead Sea Scrolls. Cell. 2020;181(6):1218-1231.e27. doi:10.1016/j.cell.2020.04.046.

Read more:
What's the Physiological Relevance? A Profile of Oded Rechavi - Technology Networks

The Honorable Dr. Dale Layman, Founder of Robowatch, LLC, is Recognized as the 2020 Humanitarian of the Year by Top 100 Registry, Inc. – IT News…

PR.com2020-09-03

Joliet, IL, September 03, 2020 --(PR.com)-- The Honorable Dr. Dale Pierre Layman, A.S., B.S., M.S., Ed.S., Ph.D. #1, Ph.D. #2, Grand Ph.D. in Medicine, MOIF, FABI, DG, DDG, LPIBA, IOM, AdVMed, AGE, is the Founder and President of Robowatch, L.L.C. (www.robowatch.info.) Robowatch is an international non-profit group aiming to keep a watchful human eye on the fast-moving developments occurring in the fields of robotics, computing, and Artificial Intelligence (A.I.) industries. As the first person in his family to attend college in 1968, he earned an Associate of Science (A.S.) in Life Science from Lake Michigan College. The same year, he won a Michigan Public Junior College Transfer Scholarship to the University of Michigan in Ann Arbor. In 1971, he received an Interdepartmental B.S. with Distinction, in Anthropology - Zoology, from the University of Michigan. From 1971 to 1972, Dr. Layman served as a Histological Technician in the Department of Neuropathology at the University of Michigan Medical School. From 1972 to 1974, he attended the U of M Medical School, Physiology department, and was a Teaching Fellow of Human Physiology. He completed his M.S. in Physiology from the University of Michigan in 1974.

From 1974 to 1975, Dr. Layman served as an Instructor in the Biology Department at Lake Superior State College. In 1975, he became a full-time, permanent Instructor in the Natural Science Department of Joliet Junior College (J.J.C.) and taught Human Anatomy, Physiology, and Medical Terminology to Nursing & Allied Health students. Appointed to the Governing Board of Text & Academic Authors, he authored several textbooks, including but not limited to the Terminology of Anatomy & Physiology and Anatomy Demystified. In 2003, Dr. Layman wrote the Foreword to the Concise Encyclopedia of Robotics, Stan Gibilisco.

As a renowned scholar and book author, Dr. Layman proposed The Faculty Ranking Initiative in the State of Illinois to increase the credibility of faculty members in the States two-year colleges, which will help with research grants or publications. In 1994, the State of Illinois accepted this proposal. J.J.C. adapted the change in 2000, and Dr. Layman taught full-time from 1975 until his retirement in 2007. He returned and taught part-time from 2008 to 2010. Dr. Layman received an Ed.S. (Educational Specialist) in Physiology and Health Science from Ball State University in 1979. Then, in 1986, Dr. Layman received his first Ph.D. from the University of Illinois, in Health and Safety Studies. In 2003, Dr. Layman received a second Ph.D. and a Grand Ph.D. in Medicine, from the Academie Europeenne D Informatisation (A.E.I.) and the World Information Distributed University (WIDU). He is the first American to receive the Grand Doctor of Philosophy in Medicine.

In 1999, Dr. Layman delivered a groundbreaking speech at the National Convention of Text and Academic Authors, Park City, Utah. Here, he first publicly explained his unique concept: Compu-Think, a contraction for computer-like modes or ways of human thinking. This reflects the dire need for humans to develop more computer-like modes or ways of Natural Human thinking. This concept has important practical applications to Human Health and Well-being. In 2000, Dr. Layman gave several major talks and received top-level awards. In May of 2000, he participated in a two-week faculty exchange program with Professor Harrie van Liebergen of the Health Care Division of Koning Willem I College, Netherlands.

In 2001, after attending an open lecture on neural implants at the University of Reading, England, Dr. Layman created Robowatch. The London Diplomatic Academy published several articles about his work, such as Robowatch (2001) and Robowatch 2002: Mankind at the Brink (2002). The article Half-human and half-computer, Andrej Kikelj (2003) discussed the far-flung implications of Dr. Laymans work. Using the base of half-human, half-computer, Dr. Layman coined the name of a new disease, Psychosomatic Technophilic, which translates as an abnormal love or attraction for technology [that replaces] the body and mind. Notably, Dr. Layman was cited several times in the article Transhumanism, (Wikipedia, 2009). Further in 2009, several debates about Transhumanism were published in Wikipedia, and they identified Dr. Layman as an anti-transhumanist who first coined the phrase, Terminator argument.

In 2018, Dr. Layman was featured in the cover of Pro-Files Magazine, 8th Edition, by Marquis Whos Who. He was the Executive Spotlight in Robotics, Computers and Artificial Intelligence, in the 2018 Edition of the Top 101 Industry Experts, by Worldwide Publishing. He also appeared on the cover of the July 2018 issue of T.I.P. (Top Industry Professionals) magazine, the International Association of Top Professionals. Dr. Layman was also the recipient of the prestigious Albert Nelson Marquis Lifetime Achievement Award (2017-2018). Ever a Lifelong Student and taking classes for the past few years at J.J.C., Dr. Layman was recently inducted (2019) to his second formal induction into the worlds largest honor society for community college students, Phi Theta Kappa.

Contact Information:

Top 100 Registry Inc.

David Lerner

855-785-2514

Contact via Email

http://www.top100registry.com

Read the full story here: https://www.pr.com/press-release/820338

Press Release Distributed by PR.com

The rest is here:
The Honorable Dr. Dale Layman, Founder of Robowatch, LLC, is Recognized as the 2020 Humanitarian of the Year by Top 100 Registry, Inc. - IT News...

U of M awarded $12.5 million to create new institute to further understanding of the impact of biodiversity change on Earth – UMN News

With the goal of revolutionizing how the world understands the causes and consequences of biodiversity loss, the University of Minnesota has been awarded a $12.5 million grant by the National Science Foundation (NSF) to establish the Biology Integration Institute (BII). Based on the Twin Cities campus, it is conducted in partnership with researchers at the University of Wisconsin-Madison.

The BII is the only research institute of its kind aimed at using spectral biology to create a greater understanding of plant and vegetation biodiversity from the genome to the global scale. Spectral biology uses the way light interacts with matter in this case, plants to reveal information about their chemistry, structure and function.

We aim to uncover how the biological variation within and among species across the tree of life detected in vegetation with hyperspectral sensors from handheld instruments, aircraft and satellites using a common currency of photons reflected from the sun influences ecosystem and biosphere dynamics, said Jeannine Cavender-Bares, BII director and professor in the U of Ms College of Biological Sciences. Our ability to do this will be key to not only understanding biodiversity now, but providing the ability to track biodiversity loss in real-time around the globe.

The Institute will take advantage of NSFs National Ecological Observatory Network (NEON), with researchers seeking to advance the ability to track the causes and consequences of biodiversity loss globally through spectral imaging. The Institute will inform analysis from NASAs global Surface Biology and Geology satellite mission, which will focus in part in creating a baseline measurement of global biodiversity. UW-Madison Professor and Institute co-director Philip Townsend has been involved in advancing the satellitetoward the goal of measuring and monitoring vegetation chemistry and physiology. The satellite is set to launch around 2027.

Changes to ecosystems can have very real human impacts, affecting where people live, their livelihoods, and even the availability of food and a habitable environment, said Cavender-Bares. Our ability to track these changes across the planet is critical to meeting global biodiversity targets and managing sustainability.

The BII will incorporate spectral data into predictive models that advance theory on how lifes variation influences the Earth system in an era of rapid global change. It takes advantage of ongoing global change experiments led by Peter Reich, a professor at the U of Ms College of Food, Agricultural and Natural Resource Sciences and an Institute co-director.

Additionally, as part of the BIIs mission, the Institute aims to recruit non-traditional and underrepresented peoples in biology for mentoring and training opportunities. This also includes work to foster curiosity in young scientists by working with K-12 students and Indigenous communities through long-term mentoring programs, Market Science modules, Minute Earth videos, and partnerships with the Bell Museum, Cedar Creek Ecosystem Science Reserve and Wisconsin Tribal Conservation Association.

We are committed to promoting diversity and fostering inclusivity through our engagement activities, including with the Wisconsin Tribal Conservation Advisory Council, to share cultural and scientific knowledge, foster cultural awareness and respect, and broaden participation of Native students in graduate programs, said Amy Trowbridge, a co-PI and assistant professor in the Dept. of Entomology at UW-Madison.

The BII is funded by the National Science Foundation Award #2021898.

###

About the College of Biological SciencesThe College of Biological Sciences at the University of Minnesota is one of two colleges in the United States dedicated to the biological sciences with undergraduate majors and graduate programs that cover the spectrum of life from molecules to ecosystems. Learn more at cbs.umn.edu.

Link:
U of M awarded $12.5 million to create new institute to further understanding of the impact of biodiversity change on Earth - UMN News

Active Ingredients in Sunscreen Detrimental to Freshwater Ecosystems – Technology Networks

The active ingredients found in sunscreen have detrimental effects on freshwater ecosystems, according to new research by University of Alberta biologists.

The results show that long-term exposure to ultraviolet (UV) filtersincluding avobenzone, oxybenzone, and octocryleneis lethal for some organisms living in freshwater environments. One of the largest sources of UV-filter contamination in both marine and freshwater environments is from sunscreen leaching off of the skin while swimming.

We do know that UV-filters are particularly devastating to coral reefs and cause bleaching, but there has been almost no research on what the effects are to freshwater animals, explained Aaron Boyd, graduate student in the Department of Biological Sciences and lead author on the paper. To address this, we examined the effects of UV-filters in the water flea, Daphnia magna.

The results show that exposure to UV-filters over a 48-hour period prevented the fleas from navigating through their environment. Exposure over a 14-day periodsimilar to what might occur near popular beach areasproved lethal for the tiny crustaceans.

This is particularly bad for a freshwater ecosystem as a whole, as Daphnia are an important part of the food chain for many smaller species of fish, added Boyd, who completed this research in collaboration with graduate student Connor Stewart, under the supervision of Assistant Professor Tamzin Blewett and Professor Keith Tierney. Losing a Daphnia population would put all of the species that rely on them at risk of starvation, and in certain conditions could cause the local ecosystem to collapse.

The good news, Boyd explained, is that the fleas were able to recover their ability to navigate through the water once the contamination was removeda good sign for environmental recovery. These chemicals are short-lived in the environment, so if we remove the sources of pollution, then there is a reasonable chance for the organisms in those environments to recover, he said.

Further research is required to better understand the long-term impact of UV-filtersand research continues in the search for non-toxic UV filters.

ReferenceBoyd A, Stewart CB, Philibert DA, et al. A burning issue: The effect of organic ultraviolet filter exposure on the behaviour and physiology of Daphnia magna. Science of The Total Environment. 2021;750:141707. doi:10.1016/j.scitotenv.2020.141707

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Read the original post:
Active Ingredients in Sunscreen Detrimental to Freshwater Ecosystems - Technology Networks

Diagnostic Errors in the COVID-19 Era – Medscape

Editor's note: Some details have been changed to protect the patient's identity.

Jaya Mallidi, MD, MHS

It was an unusually quiet Saturday afternoon on call. I was sipping coffee and leisurely reading that day's echocardiograms. On one, ordered for an indication of "dyspnea," there was a moderate-sized pericardial effusion without tamponade physiology. I called the ordering hospitalist to tell him the results.

He mentioned that the patient was admitted the previous day as a "COVID rule-out." Mr Gonzales was a 55-year-old man with progressively worsening exertional shortness of breath and cough over the previous 2 weeks. A chest x-ray showed cardiomegaly, concerning for pericardial effusion. His vital signs were stable and he was admitted with a diagnosis of viral pericarditis and high suspicion for COVID-19. Rapid SARS-CoV-2 testing was negative, but another test was ordered given the high clinical suspicion.

I called the lab for the second COVID-19 test result but was told that it would not be available for several hours. With not much clinical activity going on, I decided to go see Mr Gonzales. I donned the necessary personal protective equipment and entered his room.

Mr Gonzales was propped up in the bed. A yellow mask covered his mouth but stopped short of covering his nostrils. His eyes looked tired, like those of a man who had not slept in days. I introduced myself and asked how he was doing. After a long pause, he shook his head and mumbled, "Not good." His voice was unusually hoarse. He could not lie flat comfortably. He could not walk 10 yards without dyspnea. I wondered whether the effusion needed to be tapped. Unusual to have this degree of symptoms without any tamponade physiology.

As I stood at his bedside, unsure of what to do, he raised his hands to the sides of his neck. "It's swollen, my neck," he said. That's when I noticed that his neck was somewhat thick, more than what one would expect for his sturdy build. The supraclavicular fossa (the indentation above the clavicular bone) was obliterated and full. On palpation, I felt the hard, irregular surface of the supraclavicular lymph nodes. Check for malignancy, I thought. I informed him that we would need to do a CT scan of his neck and chest to find out what is going on.

Diagnostic errors, either missed, inaccurate, or delayed, were a common source of potential patient harm even before this pandemic. The Institute of Medicine, in its report "Improving Diagnosis in Health Care," defined diagnostic error as the failure to establish an accurate and timely explanation of the patient's health problem or communicate that problem to the patient.

Cognitive shortcuts to aid in decision-making are important sources of diagnostic error in medicine. Traditionally the diagnostic process is iterative. Accuracy and timeliness are subjective and largely depend on the patient's clinical presentation. In the COVID-19 era, an accurate diagnosis is focused on ruling the disease in or out, and the rest of the diagnostic workup begins only after this. While these new processes are important from a public health standpoint, for an individual patient, especially one presenting with a non-COVID-19 illness, the virus has become a hurdle in the diagnostic process, already strained by cognitive biases and system-based errors (Figure).

Adapted from Improving Diagnosis in Health Care .

A recent perspective by two patient quality and safety experts, Tejal Gandhi and Hardeep Singh, describes several types of anticipated diagnostic errors in the COVID-19 era. With universal availability of testing, missing COVID-19 in a patient presenting to the ED is unlikely. The more relevant error at this phase of the pandemic is a delayed or missed non-COVID diagnosis. The following common clinical fallacies can lead to diagnostic errors, especially now.

Anchoring bias. This cognitive bias occurs when the decision-making is predominantly based on the initial information provided. With Mr Gonzales, the initial framing was toward COVID-19. It was such a strong anchor that even rapid negative testing did not result in a reevaluation of the diagnosis. In the past few months, I have personally witnessed and read case reports of common disorders such as acute myocardial infarction being missed because of anchoring to a COVID-19 diagnosis.

Availability bias. With the raging pandemic, we physicians have COVID-19 on our minds. All patients presenting with respiratory complaints are assumed to have COVID-19 unless proven otherwise, because this is the most readily available explanation.

Base rate neglect. The prevalence of SARS-CoV-2 has significant geographical variation. In an area with low prevalence, a patient who presents with respiratory symptoms has a higher probability of a non-COVID condition, such as pulmonary edema from myocardial infarction, bacterial pneumonia, bronchitis, COPD, or heart failure. However, the underlying population-based prevalence is often ignored in everyday clinical medicine.

The tainted practice of modern medicine, where physicians review the EHR before meeting patients, as well as the note bloat from copy-paste problem lists, is a perfect set-up for diagnostic errors. To avoid errors and overcome our cognitive biases, we need to spend adequate time with patients, carefully integrating history, examination, and test results. In the fast-paced, chaotic world of modern medicine, where compensation rewards volume and not cognitive thinking, this needed time is missing.

Instead, we have burnout associated with the pressure to see more patients and generate more wRVUs. During a pandemic, there are new care processes, specific to each hospital, to rule out/rule in COVID-19, not to mention the rational fear for our own safety and the mental fatigue associated with that.

The risk for diagnostic errors is enhanced in this kind of environment. It can be difficult to measure this kind of error, and to date, we do not have objective data to definitively prove that there are more diagnostic errors in the COVID-19 era. I suspect, however, that the rate of diagnostic errors is higher than in pre-pandemic times. It's important for physicians to be extra vigilant during this period.

The CT scan of Mr Gonzales' chest and neck showed a mass in his lung that extended to the mediastinal structures causing significant laryngeal edema (and his hoarse voice) and superior vena cava syndrome. An urgent biopsy found stage IV adenocarcinoma of the lung. Given the patient's significant respiratory symptoms, the oncologist initiated in-patient radiation treatment in addition to intravenous steroids. Later, Mr Gonzales asked me why no one did the CT scan earlier despite him complaining about his swollen neck. Cognitive bias; a near miss, I thought. "We had to make sure COVID was ruled out," I answered.

Jaya Mallidi is an interventional cardiologist in Santa Rosa, California. An ardent patient advocate, she writes opinion pieces using patient stories as context to highlight problems in the practice of modern-day medicine. In addition, she enjoys digital sketching and playing tennis.

Follow Jaya Mallidi on Twitter

Follow theheart.org | Medscape Cardiology on Twitter

Follow Medscape on Facebook, Twitter, Instagram, and YouTube

Read the original post:
Diagnostic Errors in the COVID-19 Era - Medscape

Peloton Introduces Its First-Ever Health And Wellness Advisory Council – PRNewswire

NEW YORK, Sept. 1, 2020 /PRNewswire/ -- Peloton (NASDAQ: PTON), the world's largest interactive fitness platform, today announced the formation of the Peloton Health and Wellness Advisory Council, which will work closely with the company as it continues to look at how it can positively impact the physical, mental and emotional wellbeing of its community of Members from around the world. Peloton will collaborate with the council, which includes five renowned doctors, researchers and other medical professionals from the fields of cardiovascular medicine, cardiopulmonary exercise, neurology and neuroscience, and draw on their knowledge and expertise to help inform product and content development, community-focused and social impact initiatives, research projects and more.

"We constantly hear from our Members that Peloton has not only profoundly impacted their physical, mental and emotional health, but has also helped them cope with issues ranging from neurodegenerative disease or cancer, to PTSD or post-partum depression," said William Lynch, president, Peloton. "With the addition of this esteemed Health and Wellness Advisory Council, which includes some of the best minds in medicine, we can leverage scientific research and medical expertise to help us better serve our community through our content, products and platform."

The Peloton Health and Wellness Advisory Council includes the following experts:

Cardiovascular MedicineSuzanne Steinbaum, MD:Dr. Suzanne Steinbaum is an attending cardiologist, specializing in prevention. She has recently opened a private practice in New York City, at the Juhi-Ash integrative health center encompassing heart health, wellness and prevention, as well as the effects of stress and inflammation on heart health. She is the founder and President of SRSHeart, a personalized lifestyle management program using anatomy, physiology, functional data, genetics and metabolism, along with technology to reach ultimate cardiovascular health. She has been the Director of Women's Cardiovascular Prevention, Health and Wellness at Mt. Sinai Heart in New York City, after being the Director of Women's Heart Health at Northwell Lenox Hill. Dr. Steinbaum is a Fellow of the American College of Cardiology and the American Heart Association. She is a National Spokesperson for the Go Red for Women campaign and chairperson of the Go Red for Women in New York City. She is on the New York City Board of the American Heart Association and on the Scientific Advisory Board of the Women's Heart Alliance.

NeurologyRichard S. Isaacson, MD:Richard S. Isaacson, M.D. is a Neurologist, clinician and researcher who specializes in Alzheimer's prevention and treatment. He previously served as Associate Professor of Clinical Neurology, Vice Chair of Education, and Education Director of the McKnight Brain Institute in the Department of Neurology at the University of Miami (UM) Miller School of Medicine. Prior to joining UM, he served as Associate Medical Director of the Wien Center for Alzheimer's disease and Memory Disorders at Mount Sinai. Dr. Isaacson specializes in Alzheimer's disease (AD) risk reduction and treatment, mild cognitive impairment due to AD and preclinical AD. His clinical research has shown that individualized clinical management of patients at risk for AD dementia is an important strategy for optimizing cognitive function and reducing risk of dementia. He has also published novel methods on using a precision medicine approach in real-world clinical practice. He has also led the development of Alzheimer's Universe (AlzU.org) a vast online education research portal on AD with results published in the Journal of the Prevention of Alzheimer's disease, Journal of Communication in Healthcare, Alzheimer's & Dementia: Translational Research & Clinical Interventions, and Neurology. With a robust clinical practice and broad background in computer science, m-Health, biotechnology and web-development, Dr. Isaacson is committed to using technology and lifestyle interventions (such as physical exercise and nutrition) to optimize patient care, AD risk assessment and early intervention.

Vernon Williams, MD:Vernon Williams, MD is the Founding Director of the Center for Sports Neurology and Pain Medicine at Cedars-Sinai Kerlan-Jobe Institute in Los Angeles, CA. Dr. Williams is a former Commissioner for the California State Athletic Commission and current Chair of Neurological Health for the Commission's Medical Advisory Committee, as well as a former two-term Chair of the American Academy of Neurology Sports Neurology Section. He serves as a neurological medical consultant to local professional sports organizations such as the Los Angeles Rams, Los Angeles Dodgers, Los Angeles Lakers, Los Angeles Kings and Los Angeles Sparks. He also assists local colleges and numerous high school and youth sports/club athletic teams in this capacity. Dr. Williams is a board-certified clinical neurologist with very specialized areas of subspecialty: Sports Neurology and Pain Medicine. He is actively engaged in researching and developing innovative and effective treatments and technologies that help people recognize symptoms of a neurological injury sooner so that the work of treating them can happen faster, and with less potential for permanent damage. He passionately advocates for optimization of Neurological Health across the lifespan for his patients and peak performance clients.

Cardiopulmonary ExerciseAimee M. Layton, PhD:Aimee Layton, PhD is an Assistant Professor of Applied Physiology in Pediatrics in the Division of Pediatric Cardiology and the Director of the Pediatric Cardiopulmonary Exercise Laboratory at Columbia University Medical Center / New York Presbyterian Hospital. Dr. Layton recently joined the pediatric cardiology team after being director of the adult pulmonary exercise laboratory for a decade. This cross discipline experience provides Dr. Layton with knowledge of both how the lungs and the heart respond to exercise and the role of disease and sports in both adults and kids. Dr. Layton's prior research investigated respiratory biomechanics, with publications in both diseased and healthy populations. Her new research focuses on bridging the gap between the lab and the home, in hopes of impacting kids' behavior and relationship with exercise. Dr. Layton is a respected expert in clinical exercise physiology and has lectured internationally on the topic. Beyond her research, Dr. Layton has been performing exercise testing and counseling for both patients with lung disease and patients with heart disease. She plays an important role as one of the lead exercise physiologists for Columbia University Medical Center in testing, exercise counseling and research.

NeuroscienceJay Alberts, PhD:As a Cleveland Clinic Scientist, Ph.D., Jay Alberts' research is aimed at understanding the structure-function relationships within the central nervous system and evaluating the impact of behavioral and surgical interventions to improve motor and non-motor function in Parkinson's disease, stroke, Alzheimer's and other neurological populations. Human studies are currently ongoing to address these basic and translational research questions. Dr. Alberts is developing and validating new methods of using exercise and augmented and virtual reality to engage patient populations remotely. He is currently leading two multi-site clinical trials investigating the role of exercise in slowing the progression of Parkinson's disease. Dr. Alberts has led multiple successful technology initiatives aimed at better understanding patient symptoms and communicating these symptoms to providers. He is currently building AR and VR applications as prescriptive digital therapeutic systems for neurological patients. To date, Dr. Alberts has written 100 peer reviewed articles, has had uninterrupted extramural funding since 1999 and holds 10 patents.

For more information about Peloton or the Peloton Health and Wellness Advisory Council, please visit http://www.blog.onepeloton.com.

About PelotonPeloton is the largest interactive fitness platform in the world with a loyal community of more than 2.6 million Members. The company pioneered connected, technology-enabled fitness, and the streaming of immersive, instructor-led boutique classes for its Members anytime, anywhere. Peloton makes fitness entertaining, approachable, effective, and convenient, while fostering social connections that encourage its Members to be the best versions of themselves. An innovator at the nexus of fitness, technology, and media, Peloton has reinvented the fitness industry by developing a first-of-its-kind subscription platform that seamlessly combines the best equipment, proprietary networked software, and world-class streaming digital fitness and wellness content, creating a product that its Members love. The brand's immersive content is accessible through the Peloton Bike, Peloton Tread, and Peloton App, which allows access to a full slate of fitness classes across disciplines, on any iOS or Android device, Apple TV, Fire TV, Roku TVs, and Chromecast and Android TV. Founded in 2012 and headquartered in New York City, Peloton has a growing number of retail showrooms across the US, UK, Canada and Germany. For more information, visit http://www.onepeloton.com.

SOURCE Peloton

http://www.pelotoncycle.com

Originally posted here:
Peloton Introduces Its First-Ever Health And Wellness Advisory Council - PRNewswire